The financial liability of the federal government (CMS), Medicare enrollees, Part D sponsors, and drug manufacturers will change next year. In 2025, gap coverage will be eliminated and CMS will only contribute 40% of the cost for generic prescription drugs and 20% for brand-name drugs compared to today’s 80% contribution for both brand and generic prescription drugs.
Costs are shifting.
Costs of prescription drug coverage will shift from CMS and the retiree member to health plans and drug manufacturers. How will this impact yourGroup Medicare Part D plan and what actionable steps should you take to minimize potential financial impact?Save your seat in our live webinar, learn from our experts, and get ahead of change in 2025.
In our second informational webinar on CMS changes, RetireeFirst CEO John P. Dulczak and Chief Product Officer Sheela Andrews, Pharm D., will review important updates outlined in the CMS final rule and implications to Group Medicare Advantage and Part D benefit plans in 2025.
Presenters:
John P. Dulczak
Chief Executive Officer
RetireeFirst
Sheela Andrews, Pharm D.
Chief Product Officer
RetireeFirst
About RetireeFirst
We are the premier Retiree Benefits Management provider, enhancing the experience and outcomes for group plan sponsors and their retirees. We provide an end-to-end solution built on three pillars: Strategy, Support, and Advocacy, and partner with brokers, consultants, and clients to meet their unique needs—ultimately reducing costs while preserving group retiree benefits.
